Specifically, Ban and co-workers have reported that the expression of Fyn is significantly increased in CML patients in BC as compared to those in CP and that the overexpression of BCR-ABL was associated with up-regulation of transcription and translation of Fyn [36]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.